ClinicalTrials.Veeva

Menu
S

Szpital Wojewodzki im. Mikolaja Kopernika w Koszalinie | Oddzial Onkologii Klinicznej z Pododdzialem Chemioterapii Jednodniowej

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Pembrolizumab
MK-6482
MK-7902
MK-1084

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 3 total trials

A Clinical Study of Intismeran Autogene (V940) Treatment and Pembrolizumab in People With Bladder Cancer (V940-005/INTerpath-005)

Researchers are looking for new ways to treat people with high-risk muscle-invasive urothelial carcinoma (MIUC). Urothelial carcinoma is a type of bl...

Active, not recruiting
Bladder Cancer
Biological: Intismeran autogene
Biological: Enfortumab Vedotin

This is a study evaluating the safety, pharmacokinetics, and efficacy of calderasib alone, and calderasib plus other combination therapies in partici...

Enrolling
Advanced Solid Tumors
Biological: cetuximab
Drug: carboplatin

The goal of this study is to evaluate the efficacy and safety of pembrolizumab plus belzutifan plus lenvatinib or pembrolizumab/quavonlimab plus lenv...

Active, not recruiting
Carcinoma, Renal Cell
Drug: Belzutifan
Biological: Pembrolizumab/Quavonlimab

Trial sponsors

Merck Sharp & Dohme (MSD) logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems